You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
步長製藥(603858.SH):公司產品丹紅注射液繼續納入國家醫保目錄
格隆匯 12-29 16:09

格隆匯12月29日丨步長製藥(603858.SH)公佈,2020年12月28日,國家醫保局、人力資源社會保障部印發了《國家基本醫療保險、工傷保險和生育保險藥品目錄(2020年)》的通知,根據該通知,公司全資子公司山東丹紅製藥有限公司(以下簡稱“山東丹紅”)生產的丹紅注射液經談判繼續納入《國家醫保目錄》。

丹紅注射液的功能主治為活血化瘀,通脈舒絡。用於淤血閉阻所致的胸痺及中風,證見:胸痛,胸悶,心悸,口眼歪斜,言語蹇澀,肢體麻木,活動不利等症;冠心病、心絞痛、心肌梗塞,淤血型肺心病,缺血性腦病、腦血栓。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account